臨床試験市場- フェーズ別、治験デザイン別、治療領域別＆予測、2023年～2032年

アジア太平洋地域における臨床試験の増加により、世界の臨床試験市場規模は2032年までに高い評価を記録すると予想されています。

慢性疾患の負担が増加し続けていることが、この地域における臨床試験の必要性を高めています。WHOによると、インドでは2,500万人が糖尿病予備軍であると推定されています。

業界における製品革新の激化は、市場の拡大にさらに寄与しています。例えば、2022年10月、大手臨床研究機関であるICON plcは、炭疽菌ワクチンの臨床試験を実施するために米国バイオメディカル先端研究開発局から選ばれたことを発表しました。

臨床試験業界全体は、フェーズ、試験デザイン、治療領域、地域の観点から区分されます。

フェーズに基づくと、フェーズIセグメントからの臨床試験市場シェアは2032年まで大幅に成長すると予想されます。第I相の臨床試験結果は、医薬品開発をさらに進めるための背景となるものです。これらの試験では、副作用、安全性、患者への適切な投与量などが検討されます。さらに、最近の調査手法の進歩による第I相臨床試験の高い有効性が、セグメントの成長にプラスに寄与しています。

研究デザインに基づくと、観察研究の市場規模は2022年に110億米ドル以上を記録しました。観察研究の費用対効果は、インターベンションやエクスパンデッドアクセスと比較して優れているため、この分野の拡大に有利に働くと考えられます。これらの研究は迅速であり、研究者に現実の状況で何が起こっているかについての洞察を提供します。さらに、稀な結果や珍しい副作用を調査するのに有用であることから、今後10年間はその採用が進むでしょう。

治療分野別では、オンコロジー分野の臨床試験市場の売上が2032年まで大きく成長すると予測されています。がん患者の増加と、それに伴う政府によるがん研究への投資の増加が、この分野の成長に有利に働いています。例えば、2023年1月、カナダ政府は、小児がん研究のためのカナダ小児がんコンソーシアム設立のために、カナダ保健研究所（CIHR）から2,300万米ドル以上の投資を発表しました。このような研究開発イニシアチブの増加は、今後数年間における臨床試験の需要を増大させるでしょう。

欧州の臨床試験産業は、2032年までに230億米ドル以上の規模になると予想されています。臨床研究数の増加や、臨床研究に対する政府の支援は、この地域の拡大に貢献すると考えられます。実際、この地域には、欧州CRO連盟（EUCROF）のような、高品質の臨床研究を提供する多くの協会があります。さらに、慢性疾患の有病率の高まりが、この地域における臨床研究の必要性をさらに高めています。

目次

第1章 調査手法

• 調査手法
• 市場範囲と定義
• 基本推定と作業内容
• 予測パラメータ
• COVID-19の世界レベルでの影響分析
• データ検証
• データソース
  • 一次データ
  • 2次データ
    • 有償ソース
    • 公的な情報源

第2章 エグゼクティブサマリー

第3章 臨床試験業界洞察

• 業界のセグメンテーション
• 業界情勢、2018年～2032年
• 業界への影響要因
  • 促進要因
    • 世界の慢性疾患の有病率の増加
    • CROへの臨床試験アウトソーシングの需要の高まり
    • 臨床試験に対する政府および非政府の資金提供の増加
    • アジア太平洋諸国における臨床試験実施の機会拡大
  • 業界の潜在的リスク＆課題
    • 臨床研究における熟練労働者の不足
    • 新興諸国におけるインフラ面での障壁
    • 北米・欧州における臨床試験実施のための課題
• 成長性分析
  • フェーズ別
  • 治験デザイン別
  • 治療領域別
• COVID-19の影響分析
• 臨床試験数量の分析
  • 臨床試験数量の分析、地域別、2018年-2022年
  • 臨床試験量分析、開発段階別、2018年-2022年
  • 臨床試験数量の分析、適応症別、2018年～2022年
• 規制状況
  • 米国
  • 欧州
  • アジア太平洋地域
    • シンガポール
    • マレーシア
    • インドネシア
    • タイ
    • 韓国
    • フィリピン
• 臨床試験- アジア太平洋地域の優位性
• ポーター分析
• PESTEL分析

第4章 競合情勢、2022年

• イントロダクション
• 企業マトリックス分析、2022年
• 戦略的ダッシュボード、2022年
• 合併・買収の状況
• 主要市場プレイヤーの競合分析
• 競合のポジショニング・マトリックス
• 戦略的展望マトリクス

第5章 臨床試験市場：フェーズ別

• 主なフェーズの動向
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

第6章 臨床試験市場：治験デザイン別

• 主な試験デザイン動向
• インターベンショナルスタディ
• 観察研究
• 拡張アクセス試験

第7章 臨床試験市場：治療領域別

• 主な治療領域動向
• 自己免疫疾患
• オンコロジー
• 循環器
• 感染症
• 皮膚科領域
• 眼科
• その他

第8章 臨床試験市場：地域別動向

• 主な地域動向
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • ロシア
  • ポーランド
  • スイス
  • オランダ
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • インドネシア
  • タイ
  • シンガポール
  • マレーシア
  • フィリピン
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
  • ペルー
  • その他ラテンアメリカ地域
• MEA
  • 南アフリカ
  • サウジアラビア
  • UAE
  • イラク
  • イスラエル
  • その他中東とアフリカ

第9章 企業プロファイル

• Thermo Fisher Scientific（PPD, Inc）
• Charles River Laboratories（MPI Research）
• Clinipace Inc
• ICON plc
• IQVIA
• Laboratory Corporation of America Holding（Covance Inc）
• Medpace
• Parexel International Corporation
• Syneos health
• The Emmes Company, LLC
• WuXi AppTec

Data Tables

• TABLE 1. Market revenue, by phases, 2022
• TABLE 2. Market share, by study design, 2022
• TABLE 3. Market revenue, by therapeutic area, 2022
• TABLE 4. Market share, by region, 2022
• TABLE 5. Global clinical trials market, 2018-2022 (USD Million)
• TABLE 6. Global clinical trials market, 2023 - 2032 (USD Million)
• TABLE 7. Global clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 8. Global clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 9. Global clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 10. Global clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 11. Global clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 12. Global clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 13. Global clinical trials market, by region, 2018-2022 (USD Million)
• TABLE 14. Global clinical trials market, by region, 2023 - 2032 (USD Million)
• TABLE 15. Industry impact forces
• TABLE 16. Clinical trials volume analysis, by region, 2018-2022
• TABLE 17. Clinical trials volume analysis, by phase development, 2018-2022
• TABLE 18. Clinical trials volume analysis, by indication, 2018-2022
• TABLE 19. Merger & acquisition landscape
• TABLE 20. Phase I market estimates and forecast, 2018-2022 (USD Million)
• TABLE 21. Phase I market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 22. Phase II market estimates and forecast, 2018-2022 (USD Million)
• TABLE 23. Phase II market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 24. Phase III market estimates and forecast, 2018-2022 (USD Million)
• TABLE 25. Phase III market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 26. Phase IV market estimates and forecast, 2018-2022 (USD Million)
• TABLE 27. Phase IV market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 28. Interventional study market estimates and forecast, 2018-2022 (USD Million)
• TABLE 29. Interventional study market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 30. Observational study market estimates and forecast, 2018-2022 (USD Million)
• TABLE 31. Observational study market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 32. Expanded access study market estimates and forecast, 2018-2022 (USD Million)
• TABLE 33. Expanded access study market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 34. Autoimmune disease market estimates and forecast, 2018-2022 (USD Million)
• TABLE 35. Autoimmune disease market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 36. Oncology market estimates and forecast, 2018-2022 (USD Million)
• TABLE 37. Oncology market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 38. Cardiology market estimates and forecast, 2018-2022 (USD Million)
• TABLE 39. Cardiology market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 40. Infectious disease market estimates and forecast, 2018-2022 (USD Million)
• TABLE 41. Infectious disease market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 42. Dermatology market estimates and forecast, 2018-2022 (USD Million)
• TABLE 43. Dermatology market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 44. Ophthalmology market estimates and forecast, 2018-2022 (USD Million)
• TABLE 45. Ophthalmology market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 46. Others market estimates and forecast, 2018-2022 (USD Million)
• TABLE 47. Others market estimates and forecast, 2023 - 2032 (USD Million)
• TABLE 48. North America clinical trials market, by country, 2018-2022 (USD Million)
• TABLE 49. North America clinical trials market, by country, 2023 - 2032 (USD Million)
• TABLE 50. North America clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 51. North America clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 52. North America clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 53. North America clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 54. North America clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 55. North America clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 56. U.S. clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 57. U.S. clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 58. U.S. clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 59. U.S. clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 60. U.S. clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 61. U.S. clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 62. Canada clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 63. Canada clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 64. Canada clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 65. Canada clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 66. Canada clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 67. Canada clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 68. Europe clinical trials market, by country, 2018-2022 (USD Million)
• TABLE 69. Europe clinical trials market, by country, 2023 - 2032 (USD Million)
• TABLE 70. Europe clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 71. Europe clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 72. Europe clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 73. Europe clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 74. Europe clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 75. Europe clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 76. Germany clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 77. Germany clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 78. Germany clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 79. Germany clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 80. Germany clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 81. Germany clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 82. UK clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 83. UK clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 84. UK clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 85. UK clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 86. UK clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 87. UK clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 88. France clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 89. France clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 90. France clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 91. France clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 92. France clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 93. France clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 94. Italy clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 95. Italy clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 96. Italy clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 97. Italy clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 98. Italy clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 99. Italy clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 100. Spain clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 101. Spain clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 102. Spain clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 103. Spain clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 104. Spain clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 105. Spain clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 106. Russia clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 107. Russia clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 108. Russia clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 109. Russia clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 110. Russia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 111. Russia clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 112. Poland clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 113. Poland clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 114. Poland clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 115. Poland clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 116. Poland clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 117. Poland clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 118. Netherlands clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 119. Netherlands clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 120. Netherlands clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 121. Netherlands clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 122. Netherlands clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 123. Netherlands clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 124. Switzerland clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 125. Switzerland clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 126. Switzerland clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 127. Switzerland clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 128. Switzerland clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 129. Switzerland clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 130. Rest of Europe clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 131. Rest of Europe clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 132. Rest of Europe clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 133. Rest of Europe clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 134. Rest of Europe clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 135. Rest of Europe clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 136. Asia Pacific clinical trials market, by country, 2018-2022 (USD Million)
• TABLE 137. Asia Pacific clinical trials market, by country, 2023 - 2032 (USD Million)
• TABLE 138. Asia Pacific clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 139. Asia Pacific clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 140. Asia Pacific clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 141. Asia Pacific clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 142. Asia Pacific clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 143. Asia Pacific clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 144. Japan clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 145. Japan clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 146. Japan clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 147. Japan clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 148. Japan clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 149. Japan clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 150. India clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 151. India clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 152. India clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 153. India clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 154. India clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 155. India clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 156. China clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 157. China clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 158. China clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 159. China clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 160. China clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 161. China clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 162. Australia clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 163. Australia clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 164. Australia clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 165. Australia clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 166. Australia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 167. Australia clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 168. South Korea clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 169. South Korea clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 170. South Korea clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 171. South Korea clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 172. South Korea clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 173. South Korea clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 174. Indonesia clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 175. Indonesia clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 176. Indonesia clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 177. Indonesia clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 178. Indonesia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 179. Indonesia clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 180. Thailand clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 181. Thailand clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 182. Thailand clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 183. Thailand clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 184. Thailand clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 185. Thailand clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 186. Singapore clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 187. Singapore clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 188. Singapore clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 189. Singapore clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 190. Singapore clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 191. Singapore clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 192. Malaysia clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 193. Malaysia clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 194. Malaysia clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 195. Malaysia clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 196. Malaysia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 197. Malaysia clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 198. Philippines clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 199. Philippines clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 200. Philippines clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 201. Philippines clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 202. Philippines clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 203. Philippines clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 204. Rest of Asia Pacific clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 205. Rest of Asia Pacific clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 206. Rest of Asia Pacific clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 207. Rest of Asia Pacific clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 208. Rest of Asia Pacific clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 209. Rest of Asia Pacific clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 210. Latin America clinical trials market, by country, 2018-2022 (USD Million)
• TABLE 211. Latin America clinical trials market, by country, 2023 - 2032 (USD Million)
• TABLE 212. Latin America clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 213. Latin America clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 214. Latin America clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 215. Latin America clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 216. Latin America clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 217. Latin America clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 218. Brazil clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 219. Brazil clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 220. Brazil clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 221. Brazil clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 222. Brazil clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 223. Brazil clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 224. Mexico clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 225. Mexico clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 226. Mexico clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 227. Mexico clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 228. Mexico clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 229. Mexico clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 230. Argentina clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 231. Argentina clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 232. Argentina clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 233. Argentina clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 234. Argentina clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 235. Argentina clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 236. Colombia clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 237. Colombia clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 238. Colombia clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 239. Colombia clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 240. Colombia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 241. Colombia clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 242. Peru clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 243. Peru clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 244. Peru clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 245. Peru clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 246. Peru clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 247. Peru clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 248. Rest of Latin America clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 249. Rest of Latin America clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 250. Rest of Latin America clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 251. Rest of Latin America clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 252. Rest of Latin America clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 253. MEA clinical trials market, by country, 2018-2022 (USD Million)
• TABLE 254. MEA clinical trials market, by country, 2023 - 2032 (USD Million)
• TABLE 255. MEA clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 256. MEA clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 257. MEA clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 258. MEA clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 259. MEA clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 260. MEA clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 261. South Africa clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 262. South Africa clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 263. South Africa clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 264. South Africa clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 265. South Africa clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 266. South Africa clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 267. Saudi Arabia clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 268. Saudi Arabia clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 269. Saudi Arabia clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 270. Saudi Arabia clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 271. Saudi Arabia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 272. Saudi Arabia clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 273. UAE clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 274. UAE clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 275. UAE clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 276. UAE clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 277. UAE clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 278. UAE clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 279. Iraq clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 280. Iraq clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 281. Iraq clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 282. Iraq clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 283. Iraq clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 284. Iraq clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 285. Israel clinical trials market, by phases, 2018-2022 (USD Million)
• TABLE 286. Israel clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 287. Israel clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 288. Israel clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 289. Israel clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 290. Israel clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)
• TABLE 291. Rest of MEA clinical trials market, by phases, 2023 - 2032 (USD Million)
• TABLE 292. Rest of MEA clinical trials market, by study design, 2018-2022 (USD Million)
• TABLE 293. Rest of MEA clinical trials market, by study design, 2023 - 2032 (USD Million)
• TABLE 294. Rest of MEA clinical trials market, by therapeutic area, 2018-2022 (USD Million)
• TABLE 295. Rest of MEA clinical trials market, by therapeutic area, 2023 - 2032 (USD Million)

Charts & Figures

• FIG. 1 GMI report coverage: Critical research elements
• FIG. 2 Industry segmentation
• FIG. 3 Bottom-up approach
• FIG. 4 Market estimation and forecast methodology
• FIG. 5 Market forecasting methodology
• FIG. 6 Breakdown of primary participants
• FIG. 7 Global clinical trials industry 360 degree synopsis, 2018 - 2032 (USD Mn)
• FIG. 8 Industry landscape, 2018 - 2032 (USD Million)
• FIG. 9 Growth potential analysis, by phases
• FIG. 10 Growth potential analysis, by study design
• FIG. 11 Growth potential analysis, by therapeutic area
• FIG. 12 Porter's analysis
• FIG. 13 PESTEL analysis
• FIG. 14 Company matrix analysis, 2022
• FIG. 15 Strategic dashboard, 2022
• FIG. 16 Competitive analysis of major market players
• FIG. 17 Competitive positioning matrix
• FIG. 18 Strategic outlook matrix

Global Clinical Trials Market size is anticipated to record an appreciable valuation by 2032, owing to the increasing prospects for performing clinical trials in the Asia Pacific. The consistent rise in the burden of chronic disorders has accentuated the need for clinical trials in the region. As per the WHO, an estimated 25 million people are prediabetic in India.

Escalating product innovations in the industry are further contributing to market expansion. For instance, in October 2022, ICON plc, a leading clinical research organization announced its selection by US Biomedical Advanced Research and Development Authority for conducting an anthrax vaccine clinical trial.

The overall clinical trials industry is segmented in terms of phases, study design, therapeutic area, and region.

Based on phases, the clinical trials market share from the phase I segment is expected to grow considerably through 2032. Phase I clinical trial results serve as the background for further progress in drug development. These studies examine the side effects, safety, and appropriate dosage level for patients. Furthermore, high efficacy of phase I clinical trials due to recent advancements in research methodologies is positively contributing to segment growth.

Based on the study design, the market size from the observational study segment recorded more than USD 11 billion in 2022. The cost-effectiveness of observational studies over their interventional and expanded access counterparts will favor segment expansion. These studies are quick and provide researchers with insights into what occurs in real-life situations. Moreover, their usefulness in investigating rare outcomes and unusual side effects will boost their adoption in the next ten years.

In terms of therapeutic area, the clinical trials market revenue from the oncology segment is poised to depict significant growth through 2032. Increasing incidences of cancer and the subsequent rise in investments by the government in cancer research are working in favor of segment growth. To illustrate, in January 2023, the government of Canada announced an investment of more than USD 23 million from the Canadian Institutes of Health Research (CIHR) for the establishment of the Canadian Pediatric Cancer Consortium for pediatric cancer research. Increasing R&D initiatives such as these will augment the demand for clinical trials in the forthcoming years.

Europe clinical trials industry is expected to be valued at over USD 23 billion by 2032. Rising number of clinical studies, along with favorable government support for clinical research, may contribute to regional expansion. In fact, the region is also home to many associations, such as the European CRO Federation (EUCROF), that provide high-quality clinical research. Moreover, the growing prevalence of chronic diseases has further increased the need for clinical research in the region.

Table of Contents

Chapter 1 Methodology

• 1.1 Methodology
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Clinical trials industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Phases trends
  • 2.1.3 Study design trends
  • 2.1.4 Therapeutic area trends
  • 2.1.5 Regional trends

Chapter 3 Clinical trials Industry Insights

• 3.1 Industry segentation
• 3.2 Industry landscape, 2018 - 2032
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Increasing prevalence of chronic diseases across the globe
    • 3.3.1.2 Growing demand for outsourcing clinical trials to CROs
    • 3.3.1.3 Rise in government and non-government funding for clinical trials
    • 3.3.1.4 Growing opportunities for conducting clinical trials in countries of Asia Pacific
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Lack of skilled workforce in clinical research
    • 3.3.2.2 Infrastructural barriers in developing countries
    • 3.3.2.3 Challenges faced in North America & Europe for conducting clinical trials
• 3.4 Growth potential analysis
  • 3.4.1 By phases
  • 3.4.2 By study design
  • 3.4.3 By therapeutic area
• 3.5 COVID-19 impact analysis
• 3.6 Clinical trials volume analysis
  • 3.6.1 Clinical trials volume analysis, by region, 2018-2022
  • 3.6.2 Clinical trials volume analysis, by phase of development, 2018-2022
  • 3.6.3 Clinical trials volume analysis, by indication, 2018-2022
• 3.7 Regulatory landscape
  • 3.7.1 U.S.
  • 3.7.2 Europe
  • 3.7.3 Asia Pacific
    • 3.7.3.1 Singapore
    • 3.7.3.2 Malaysia
    • 3.7.3.3 Indonesia
    • 3.7.3.4 Thailand
    • 3.7.3.5 South Korea
    • 3.7.3.6 Philippines
• 3.8 Clinical trials - Asia Pacific advantage
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Strategic dashboard, 2022
• 4.4 Merger & Acquisition landscape
• 4.5 Competitive analysis of major market players
• 4.6 Competitive positioning matrix
• 4.7 Strategic outlook matrix

Chapter 5 Clinical Trials Market, By Phases

• 5.1 Key phases trends
• 5.2 Phase I
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 5.3 Phase II
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 5.4 Phase III
  • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 5.5 Phase IV
  • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Milion)

Chapter 6 Clinical Trials Market, By Study Design

• 6.1 Key study design trends
• 6.2 Interventional study
  • 6.2.1 Market size, by region, 2017 - 2030 USD Milion)
• 6.3 Observational study
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 6.4 Expanded access study
  • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Milion)

Chapter 7 Clinical Trials Market, By Therapeutic Area

• 7.1 Key therapeutic area trends
• 7.2 Autoimmune disease
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 7.3 Oncology
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 7.4 Cardiology
  • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 7.5 Infectious disease
  • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 7.6 Dermatology
  • 7.6.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 7.7 Ophthalmology
  • 7.7.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
• 7.8 Others
  • 7.8.1 Market estimates and forecast, 2018 - 2032 (USD Milion)

Chapter 8 Clinical trials Market, By Region

• 8.1 Key regional trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
  • 8.3.7 Poland
  • 8.3.8 Switzerland
  • 8.3.9 Netherlands
  • 8.3.10 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Indonesia
  • 8.4.7 Thailand
  • 8.4.8 Singapore
  • 8.4.9 Malaysia
  • 8.4.10 Philippines
  • 8.4.11 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Colombia
  • 8.5.5 Peru
  • 8.5.6 Rest of Latin America
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Iraq
  • 8.6.5 Israel
  • 8.6.6 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Thermo Fisher Scientific (PPD, Inc)
• 9.2 Charles River Laboratories (MPI Research)
• 9.3 Clinipace Inc
• 9.4 ICON plc
• 9.5 IQVIA
• 9.6 Laboratory Corporation of America Holding (Covance Inc)
• 9.7 Medpace
• 9.8 Parexel International Corporation
• 9.9 Syneos health
• 9.10 The Emmes Company, LLC
• 9.11 WuXi AppTec